Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases

NCT06360913 is registered in ClinicalTrials.gov with Cliniques universitaires Saint-Luc- Université Catholique de Louvain as lead sponsor.

NCT NCT06360913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase
Not applicable
Overall status
Recruiting
Start date
January 3, 2024
Completion date
January 31, 2028
Enrollment
2,286 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

inborn errors of metabolism, rare diseases